Declining hepatitis C virus (HCV) prevalence in pregnant women: Impact of anti-HCV screening of donated blood: TRANSFUSION COMPLICATIONS

Transfusion

Volumn 50, Issue 3, 2010, Pages 693-700

  Ohto, Hitoshi ^a   Ishii, Tsutomu ^b   Kitazawa, Junichi ^b   Sugiyama, Seiji ^b   Ujiie, Niro ^b   Fujimori, Keiya ^b   Ariga, Hiromichi ^b   Satoh, Tomoko ^b   Nollet, Kenneth E ^b   Okamoto, Hiroaki ^b   Hoshi, Tanji ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANCY; VIRUS TRANSMISSION;

BLOOD DONORS; COHORT STUDIES; DONOR SELECTION; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; JAPAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RNA, VIRAL;

EID: 77649226940     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02487.x     Document Type: Article

References (34)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M : Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989 244 : 359 62.
2. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBiseglie A, Hoofnagle J, Shih JW, Kaslow R, Ness P, Alter H. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996 334 : 1691 6.
3. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, Nass CC, Ownby HE, Schreiber GB, Kong F, Neal KR, Nemo GJ. Risk factors for hepatitis C virus infection in United States blood donors. Hepatology 2000 31 : 756 62.
4. O'Brien SF, Fan W, Xi G, Yi QL, Goldman M, Fearon MA, Infante-Rivard C, Chiavetta A, Willems B, Pi D, Fast M, Delage G. Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies. Transfusion 2008 48 : 902 9.
5. Alter MJ, Kruszon-Moran D, Mainan OV, McQuilian GM, Gao F, Moyer LA, Kaslow RA, Margolis H. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999 341 : 556 62.
6. Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, Kako M, Ujiie N, Endo C, Matsui A, Okamoto H, Mishiro S the Vertical Transmission of Hepatitis C Virus Collaborative Study Group. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994 330 : 744 50.
7. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990 60 : 215 22.
8. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology 1994 20 : 1131 6.
9. Finkel, SE. Causal analysis with panel data. Thousand Oaks (CA) : Sage Publications 1995.
10. Ishii T, Ohto H, Takeuchi C, Ariga H, Hirai S, Ujiie N, Suzuki H, Okamoto H. Evolution in the hypervariable region of the hepatitis C virus in two infants infected by mother-to-infant transmission. Pediatr Int 2005 47 : 278 85.
11. Moriya T, Koyama T, Tanaka J, Mishiro S, Yoshizawa H. Epidemiology of hepatitis C virus in Japan. Intervirology 1999 42 : 153 8.
12. Murokawa H, Yoshikawa A, Ohnuma H, Iwata A, Katoh N, Miyamoto M, Mine H, Emura H, Tadokoro K the Japanese Red Cross NAT Screening Research Group. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang 2005 88 : 10 6.
13. Widell A, Busch M. Exposed or not exposed - that is the question: evidence for resolving and abortive hepatitis C virus infections in blood donors. Transfusion 2009 49 : 1277 81.
14. Bes M, Esteban JI, Casamitjana N, Piron M, Quer J, Cubero M, Puig L, Guardia J, Sauleda S. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure. Transfusion 2009 49 : 1296 305.
15. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, Reitz BA, Nelson KE. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992 327 : 369 73.
16. Japanese Red Cross NAT Screening Research Group. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood for transfusion and follow-up study of nucleic acid amplification positive donors. Jpn J Infect Dis 2000 53 : 116 23.
17. Japanese Red Cross NAT Screening Research Group. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV. Microbiol Immunol 2001 45 : 667 72.
18. Japanese Red Cross Blood Service Headquarters. [Improved safety in blood components. Transfusion Information 2008 116 in Japanese). Available from: URL: http://www.jrc.or.jp/mr/top.html
19. NIH consensus statement on management of hepatitis C: 2002. NIH Consens State Sci Stat 2002 19 : 1 46.
20. Lin HH, Kao JH, Hsu HY, Ni YH, Yeh SH, Hwang LH, Chang MH, Hwang SC, Chen PJ, Chen DS. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 1994 169 : 638 41.
21. Okamoto M, Nagata I, Murakami J, Kaji S, Iitsuka T, Hoshika T, Matsuda R, Tazawa Y, Shiraki K, Hino S. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 2000 182 : 1511 4.
22. Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002 36 : S106 13.
23. Boxall E, Baumann K, Price N, Sira J, Brown M, Kelly D. Discordant outcome of perinatal transmission of hepatitis C in twin pregnancies. J Clin Virol 2007 38 : 91 5.
24. Centers for Disease Control and Prevention. Public Health Service interagency guidelines for screening blood, plasma, organs, tissue and semen for evidence of hepatitis B and C. MMWR 1991 40 : 1 23.
25. Martínez-Bauer E, Forns X, Armelles M, Planas R, Solà R, Vergara M, Fàbregas S, Vega R, Salmerón J, Diago M, Sánchez-Tapias JM, Bruguera M Spanish Acute HCV Study Group. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain. J Hepatol 2008 48 : 20 7.
26. Prati D, Capelli C, Silvanti C, Mattei C, Bosoni P, Pappalettera M, Mozzi F, Colombo M, Zanella A, Sirchia G. The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors. Hepatology 1997 25 : 702 4.
27. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008 48 : 148 62.
28. Salleras L, Bruguera M, Vidal J, Plans P, Dominguez A, Salleras M, Navas E, Gali N. Importance of sexual transmission of hepatitis C virus in seropositive pregnant women: a case control study. J Med Virol 1997 52 : 164 7.
29. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997 26 : 62S 5S.
30. Kojima M, Kanazawa K, Hakamada T, Aikawa T. [Infection with hepatitis GB virus C in intravenous drug abusers with type C chronic liver diseases.] Nippon Rinsho 1997 55 : 549 53 (in Japanese).
31. Ide T, Ogata K, Sada M. [Epidemiologic change in acute hepatitis C.] Kan-Tan-Sui 2003 47 : 625 31 (in Japanese).
32. Wada K, Shimane T, Kondoh A Nationwide survey for drug use in Japan. Report of research on regulatory science of pharmaceuticals and medical devices, 2007. 2008. p. 15 82 in Japanese) or Available from: URL http://www.ncnp.go.jp/ nimh/yakubutsu/drug-top/data/researchJDU2007.pdf
33. Sun CA, Chen HC, Lu CF, You SL, Mau YC, Ho MS, Lin SH, Chen CJ. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide study. J Med Virol 1999 59 : 290 6.
34. Tamori A, Shibata H, Yoshizawa K. [Real figure of transfusion-related viral infections with a sequential study.] Jpn J Transfus Med 2006 52 : 198 (in Japanese) (Abstract).